SBI Pharma Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
2ndary - Private
SBI Pharma General Information
Description
Developer of a biotechnology platform designed to commercialize 5-aminolevulinic acid for applications in health and medicine. The company offers proprietary 5-ALA manufacturing methods and a range of products in healthcare, cosmetics, and diagnostics, enabling individuals, patients, and aging populations to support metabolic function, improve health, and aid in disease detection.
Contact Information
Website
www.sbipharma.co.jpCorporate Office
- Izumi Garden Tower 20th Floor, 1-6-1
- Roppongi, Minato-ku, Direct link with Roppongi 1-chome Station
- Tokyo, 106-6020
- Japan
Corporate Office
- Izumi Garden Tower 20th Floor, 1-6-1
- Roppongi, Minato-ku, Direct link with Roppongi 1-chome Station
- Tokyo, 106-6020
- Japan
SBI Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Dec-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | Completed | Generating Revenue |
SBI Pharma Patents
SBI Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023228176-A1 | Pharmaceutical composition for preventing and/or treating autoimmune diseases | Pending | 01-Mar-2022 | ||
| EP-4487843-A1 | Pharmaceutical composition for preventing and/or treating autoimmune diseases | Pending | 01-Mar-2022 | ||
| EP-4487843-A4 | Pharmaceutical composition for preventing and/or treating autoimmune diseases | Pending | 01-Mar-2022 | ||
| JP-7628237-B2 | Pharmaceutical composition for preventing and/or treating autoimmune diseases | Active | 01-Mar-2022 | ||
| US-20250262179-A1 | Pharmaceutical composition for preventing and/or treating autoimmune diseases | Pending | 01-Mar-2022 | A61K31/197 |
SBI Pharma Signals
SBI Pharma Investments (1)
SBI Pharma’s most recent deal was a Joint Venture with SBI Neopharma FZ. The deal was made on 01-Dec-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| SBI Neopharma FZ | 01-Dec-2016 | Joint Venture | Biotechnology |
SBI Pharma FAQs
-
When was SBI Pharma founded?
SBI Pharma was founded in 2008.
-
Where is SBI Pharma headquartered?
SBI Pharma is headquartered in Tokyo, Japan.
-
What is the size of SBI Pharma?
SBI Pharma has 50 total employees.
-
What industry is SBI Pharma in?
SBI Pharma’s primary industry is Pharmaceuticals.
-
Is SBI Pharma a private or public company?
SBI Pharma is a Private company.
-
What is SBI Pharma’s current revenue?
The current revenue for SBI Pharma is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process